Medication info
Keglitto Tablets 25/5 mg (Empagliflozin, Linagliptin Besilate)

Keglitto Tablets 25/5 mg (Empagliflozin, Linagliptin Besilate)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tabletLinagliptin Besylate›6.67mg / 1 tablet
Manufacturer / importer
Kyunbo Pharmaceutical Co., Ltd.
Appearance
Flat on both sides with sharp edges, pink triangular film-coated tablet
Packaging
10 tablets/PTP, 30 tablets/PTP [(10 tablets/PTP×3)]
Approval status
Active

MFDS item code 202503048 · Approved 2025.11.21

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg (equivalent to 6.67mg of linagliptin besylate) once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this medicine may be increased to 25/5 mg (equivalent to 6.67mg of linagliptin besylate) once daily. Patients switching from combination therapy with empagliflozin and linagliptin to this medicine should receive the same doses they were previously taking. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Special populations Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Ingredients

Manufacturer
Kyunbo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used alongside dietary therapy and exercise to help patients with type 2 diabetes control their blood sugar levels. The combined administration of empagliflozin and linagliptin effectively improves blood sugar levels and aids in diabetes management for patients. Continuous safe use enhances blood sugar control, supporting maintenance of a healthy lifestyle.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg (equivalent to 6.67mg of linagliptin besylate) once daily. For patients who tolerate empagliflozin 10 mg/linagliptin 5 mg but require additional glycemic control, the dose of this medicine may be increased to 25/5 mg (equivalent to 6.67mg of linagliptin besylate) once daily. Patients switching from combination therapy with empagliflozin and linagliptin to this medicine should receive the same doses they were previously taking. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Special populations Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.

Precautions

This medication contains two active ingredients, empagliflozin and linagliptin, which assist in blood sugar control. However, this medication should not be used in certain patients for safety reasons. For instance, it should not be administered to individuals who have an allergy to the components, those with type 1 diabetes, diabetic ketoacidosis, or patients undergoing dialysis. Additionally, it should be used with caution in patients with decreased kidney function or heart failure. Because kidney function can influence the efficacy of this medication, it is important to regularly monitor kidney function before and during treatment. During the course of taking this medication, rare side effects such as acute pancreatitis or bullous pemphigoid may occur; thus, patients should inform their doctor immediately if they experience severe abdominal pain or skin blisters. The most common side effect is urinary tract infection, which may occur more frequently in women. Other possible symptoms include genital infections, increased urination, fluid loss, and symptoms of hypoglycemia. Particularly, when taken with sulfonylureas or insulin, there is an increased risk of hypoglycemia, so blood sugar levels should be monitored frequently, and medication dosage adjusted if necessary. This medication may lower blood pressure, thus requiring more caution for patients with cardiovascular disease, elderly patients, or those with hypotension. If dehydration or fluid loss is suspected, immediate consultation with medical personnel is necessary. Pregnant or nursing women are advised not to take this medication, and particularly during breastfeeding, it is recommended to discontinue breastfeeding. Moreover, caution is necessary when driving or operating machinery due to the risk of hypoglycemia. Long-term use of this medication may report an increased risk of amputations of toes or lower limbs, so it is crucial to manage foot health carefully. Lastly, during the course of this medication, interactions with other drugs may occur, so it is essential to inform your doctor or pharmacist if you are taking other medications.

Side effects

  • urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • genital infection
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 167 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • itching
  • rash
  • vesicular dermatitis
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • constipation
  • epigastric pain
  • enterocolitis
  • bowel obstruction
  • gastritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech impairment
  • Alzheimer's disease
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • male pattern baldness
  • diabetic foot
  • hyperhidrosis
  • hair loss
  • skin lesions
  • anxiety
  • mood disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • meniscus injury
  • foot fracture
  • hand fracture
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • gastroesophageal reflux disease
  • gastritis
  • headache
  • dizziness
  • chest discomfort
  • osteoarthritis
  • limb pain
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • visual disturbance
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • lattice retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • senile dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • nosebleed
  • oropharyngeal pain
  • voice impairment
  • allergic rhinitis
  • exertional dyspnea
  • moist cough
  • runny nose
  • skin laceration
  • rib fracture
  • iliotibial band syndrome
  • angina pectoris
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • vertigo
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • hypoglycemia
  • obesity
  • hyperphagia
  • diabetes
  • hyperlipidemia
  • hyponatremia
  • vitamin D deficiency

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's efficacy and safety over time.

Appearance and packaging

Appearance

Flat on both sides with sharp edges, pink triangular film-coated tablet

Package unit

10 tablets/PTP, 30 tablets/PTP [(10 tablets/PTP×3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.